Now, the gamechanger is obviously AI - transformative at most, if not all, levels of the business. Founders and businesses ...
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the co-formulation of ASC36, a once-monthly next-generation amylin receptor agonist and ASC35, a once-monthly next-generation GLP-1R/GIPR dual ...